• SPX
  • $5,763.28
  • 0.89 %
  • $50.59
  • DJI
  • $42,121.89
  • 0.78 %
  • $327.28
  • N225
  • $38,474.90
  • 1.11 %
  • $421.23
  • FTSE
  • $8,176.09
  • -0.1 %
  • -$8.15
  • IXIC
  • $18,381.18
  • 1.11 %
  • $201.20
I-Mab (IMAB) Latest News

I-Mab (IMAB) Latest News

NASDAQ Currency in USD Disclaimer

Stock Price

$1.13

$0.04

(3.67%)

Day's range
$1.07
Day's range
$1.13

Latest News of IMAB

Otsuka's sibeprenlimab shows promise in Phase III IgA nephropathy trial

By Yahoo! Finance | 1 week ago

Otsuka Pharmaceutical's Phase III trial on sibeprenlimab for IgA nephropathy showed positive interim results. The monoclonal antibody demonstrated a significant reduction in urine protein levels, meet...

GSK's depemokimab shows promise in Phase III trials for chronic rhinosinusitis

By Yahoo! Finance | 3 weeks ago

GSK's Phase III trials of depemokimab in CRSwNP patients showed significant improvements compared to placebo, meeting primary endpoints. The drug's potential as a convenient treatment option is promis...

GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year

By Yahoo! Finance | 3 weeks ago

GSK plc announced positive results from phase 3 trials for depemokimab in treating chronic rhinosinusitis with nasal polyps. The trials met primary endpoints, showing efficacy and safety in reducing p...

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.